Celsius (NASDAQ:CELH – Get Free Report) had its price target dropped by analysts at UBS Group from $50.00 to $45.00 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s price objective would suggest a potential upside of 55.71% from the stock’s current price.
Other equities research analysts have also recently issued reports about the company. Truist Financial lifted their price objective on Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a research report on Wednesday, October 16th. Maxim Group cut their price target on Celsius from $65.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, September 5th. Jefferies Financial Group lowered their price objective on shares of Celsius from $53.00 to $48.00 and set a “buy” rating for the company in a research report on Thursday, October 10th. Bank of America reduced their target price on shares of Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research report on Thursday, September 5th. Finally, Piper Sandler lowered their price target on shares of Celsius from $50.00 to $47.00 and set an “overweight” rating for the company in a report on Tuesday, September 24th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Celsius currently has an average rating of “Moderate Buy” and an average target price of $54.40.
Get Our Latest Analysis on CELH
Celsius Stock Performance
Celsius (NASDAQ:CELH – Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.05. The firm had revenue of $402.00 million for the quarter, compared to analyst estimates of $391.07 million. Celsius had a net margin of 19.58% and a return on equity of 94.75%. The business’s revenue for the quarter was up 23.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.17 EPS. On average, research analysts forecast that Celsius will post 0.79 earnings per share for the current fiscal year.
Insider Transactions at Celsius
In related news, CEO John Fieldly sold 74,847 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the sale, the chief executive officer now owns 1,812,490 shares in the company, valued at approximately $59,449,672. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 2.20% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Celsius
Several institutional investors have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Celsius by 19.7% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 64,515 shares of the company’s stock valued at $5,563,000 after buying an additional 10,634 shares during the period. Janney Montgomery Scott LLC grew its stake in Celsius by 142.2% in the first quarter. Janney Montgomery Scott LLC now owns 26,090 shares of the company’s stock valued at $2,163,000 after acquiring an additional 15,316 shares during the period. Nordea Investment Management AB increased its holdings in shares of Celsius by 41.9% in the first quarter. Nordea Investment Management AB now owns 11,550 shares of the company’s stock worth $962,000 after acquiring an additional 3,412 shares in the last quarter. Csenge Advisory Group raised its position in shares of Celsius by 8.9% during the first quarter. Csenge Advisory Group now owns 5,583 shares of the company’s stock worth $463,000 after purchasing an additional 454 shares during the period. Finally, Geneos Wealth Management Inc. lifted its holdings in shares of Celsius by 2,956.9% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,773 shares of the company’s stock valued at $147,000 after purchasing an additional 1,715 shares in the last quarter. 60.95% of the stock is currently owned by institutional investors and hedge funds.
Celsius Company Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More
- Five stocks we like better than Celsius
- Quiet Period Expirations Explained
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- How to Calculate Retirement Income: MarketBeat’s Calculator
- MarketBeat Week in Review – 11/4 – 11/8
- Following Congress Stock Trades
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.